ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Three Benefits Of Centralizing Global Content For eCOA Migration

  Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.

• Readying Your Clinical Trial For Linkage With Real-World Data

  Discover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

• DTx Company Leverages Real-World Evidence Platform In Registry Study

  Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.

• Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection

  Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.

• Achieving Faster, Simpler Validation Through Crowdsource UAT

  An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.

• Why An eTMF? It's Time For A Specialized Digital Solution

  Clinical trials generate reams of documents. Use an electronic trial master file to streamline much of the work of document management, logging, and compliance.

• The Case For Cognitive Assessments In Phase 1 Clinical Trials

  Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.

• Perspective On The FDA's Final Digital Health Technologies Guidance

  Review the final release of "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations”, where the FDA acknowledges DHT value and the increasing use of them in clinical trials.

• Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers

  For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.